⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578361 | 1.00 | — | — | |
| SCHEMBL8652579 | 0.80 | GRIK1 (0.52) | — | |
| SCHEMBL8652572 | 0.80 | GRIK1 (0.52) | — | |
| SCHEMBL7398604 | 0.78 | — | — | |
| SCHEMBL4472178 | 0.78 | — | — | |
| SCHEMBL149790 | 0.76 | — | — | |
| SCHEMBL17708334 | 0.76 | — | — | |
| SCHEMBL7383035 | 0.76 | — | — | |
| SCHEMBL40887 | 0.76 | — | — | |
| SCHEMBL149791 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012158197-A2 | COMPOUNDS USEFUL AS AKT/PKB MODULATORS AND USES THEREOF | LYNDOR BIOSCIENCES L.L.C. (US) | 2012-11-22 | — | — | WO | claimed |
| EP-1711207-A4 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX INC (US) | 2008-05-07 | — | — | EP | claimed |
| EP-1711207-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | Medarex, Inc. (US) | 2006-10-18 | — | — | EP | claimed |
| WO-2005059106-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| CN-117500510-A | Deoxynucleoside prodrugs for treating mitochondrial diseases caused by unbalanced nucleotide pools | 周格尼克斯公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-116731099-A | Nucleoside phosphoramidate prodrugs | 吉利德科学公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-116731098-A | Nucleoside phosphoramidate prodrugs | 吉利德科学公司 | 2023-09-12 | — | — | CN | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-101918425-B | Nucleoside phosphoramidate prodrugs | 吉利德科学公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-109776637-B | Nucleoside phosphoramidate prodrugs | 吉利德科学公司 | 2023-04-18 | — | — | CN | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| CN-115697383-A | Methods of treating viral infections and health problems | 艾伦·戴维多夫 | 2023-02-03 | — | — | CN | disclosed |
| EP-0606925-A2 | A method for derivatizing a 1-amino-1-deoxyoligosaccharide | Genzyme Corporation (US) | 1994-07-20 | — | — | EP | disclosed |
| US-5324828-A | Fluorescent compound | GENZYME CORPORATION (US) | 1994-06-28 | — | — | US | disclosed |
| US-5283353-A | Enzymeric cleavage from glycoprotein | GENZYME CORPORATION (US) | 1994-02-01 | — | — | US | disclosed |
| EP-0560568-A2 | Hydroquinone derivatives and intermediates for production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-09-15 | — | — | EP | disclosed |
| EP-0093376-B1 | 1-SULFO-2-AZETIDINONE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1990-03-21 | — | — | EP | disclosed |
| EP-0299007-A4 | PREPARATION OF 1-AMINO-1-DEOXYOLIGOSACCHARIDES AND DERIVATIVES THEREOF. | GENZYME CORP (US) | 1990-03-08 | — | — | EP | disclosed |
| EP-0299007-A1 | PREPARATION OF 1-AMINO-1-DEOXYOLIGOSACCHARIDES AND DERIVATIVES THEREOF | GENZYME CORPORATION (US) | 1989-01-18 | — | — | EP | disclosed |
| WO-1988004323-A1 | PREPARATION OF 1-AMINO-1-DEOXYOLIGOSACCHARIDES AND DERIVATIVES THEREOF | GENZYME CORPORATION (US) | 1988-06-16 | — | — | WO | disclosed |